Citation Impact
Citing Papers
Oxidative Stress
2017 Standout
Human Cytotrophoblast Expression of the von Hippel–Lindau Protein Is Downregulated during Uterine Invasion in Situ and Upregulated by Hypoxia in Vitro
2001 StandoutNobel
A Rating Scale for Drug-Induced Akathisia
1989 Standout
History of the Discovery and Clinical Introduction of Chlorpromazine
2005
The role of the medicinal chemist in drug discovery — then and now
2004
The influence of drug-like concepts on decision-making in medicinal chemistry
2007 Standout
The Haloperidol Story
2005
Immunostaining of the von Hippel-Lindau gene product in normal and neoplastic human tissues
1997 StandoutNobel
Antipsychotic agents in the treatment of bipolar mania
2009
Schizophrenia
2009 Standout
The 'atypicality' of antipsychotics: a concept re-examined and re-defined
2009 Nobel
Neurobiology of Dopamine in Schizophrenia
2007
von Hippel-Lindau Disease
1997 StandoutNobel
Measuring the Costs of Schizophrenia
1995
Memory and the hippocampus: A synthesis from findings with rats, monkeys, and humans.
1992 Standout
Psychosis as a State of Aberrant Salience: A Framework Linking Biology, Phenomenology, and Pharmacology in Schizophrenia
2002 Standout
von Hippel-Lindau disease
2003 Standout
Prevalence of and Risk Factors for Medication Nonadherence in Patients With Schizophrenia
2002 Standout
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway
2009 Standout
Drug discovery from medicinal plants
2005 Standout
Diagnosing the decline in pharmaceutical R&D efficiency
2012 Standout
Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients
2000 Standout
Sigma-1 Receptor Chaperones at the ER- Mitochondrion Interface Regulate Ca2+ Signaling and Cell Survival
2007 Standout
Pharmacology and Clinical Drug Candidates in Redox Medicine
2015
The effect of l-dopa on young patients with simple schizophrenia, treated with neuroleptic drugs
1975
The Medial Temporal Lobe Memory System
1991 StandoutScience
The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia
1987 Standout
Drug Action on The Electrical Activity of The Hippocampus
1965
Interneurons of the hippocampus
1998 Standout
Comparison between Akathisia Developing on Treatment with Phenothiazine Derivatives and the Restless Legs Syndrome
1961
How antipsychotics work—From receptors to reality
2006
Analysis of Past and Present Synthetic Methodologies on Medicinal Chemistry: Where Have All the New Reactions Gone?
2015 Standout
Fluorine in medicinal chemistry: Recent therapeutic applications of fluorinated small molecules
2006 Standout
Structure of the VHL-ElonginC-ElonginB Complex: Implications for VHL Tumor Suppressor Function
1999 StandoutScienceNobel
Antimicrobial photodynamic therapy – what we know and what we don’t
2018 Standout
Dopamine in schizophrenia: a review and reconceptualization
1991 Standout
The psychophysiological basis of introversion-extraversion
1970 Standout
A faulty negative feedback control underlies the schizophrenic syndrome?
1991 StandoutNobel
Receptor mechanisms in antipsychotic drug action: focus on sigma receptors
1989
Human amnesia and the medial temporal region: enduring memory impairment following a bilateral lesion limited to field CA1 of the hippocampus
1986 Standout
Hippocampal electrical activity and voluntary movement in the rat
1969 Standout
Bilateral and limited amygdalohippocampal lesions causing a pure amnesic syndrome
1985
Increased baseline occupancy of D 2 receptors by dopamine in schizophrenia
2000 Standout
Implications of Normal Brain Development for the Pathogenesis of Schizophrenia
1987 Standout
Positron Emission Tomography Reveals Elevated D 2 Dopamine Receptors in Drug-Naive Schizophrenics
1986 Science
Adverse effects of anticholinergic medication on positive schizophrenic symptoms
1983
Lindau's disease
1964
Early psychopharmacology and the rise of modern brain research
1990 StandoutNobel
Works of J Delay being referenced
Chlorpromazine and neuroleptic treatments in psychiatry.
2003
[Therapeutic use in psychiatry of phenothiazine of central elective action (4560 RP)].
1952
Familial angiomatous phakomatosis.
2010
Neuroleptic effects of chlorpromazine in therapeutics of neuropsychiatry.
1955
[Experimental neurological syndromes & psychiatric therapy. I. Neurological effects of a new important neuroleptic drug, RP 7843].
1959
[Excito-motor syndrome provoked by neuroleptic drugs].
1957
[Anatomo-clinical case of post-epileptic Korsakoff's syndrome after corticotherapy for subintrant asthma].
1965
[The action of haloperidol in psychoses].
1960
[The action of isonicotinyl-hydrazide used in the treatment of depressive states].
1952
[Modifications of the electrocardiogram of rabbits by di-ethylamide of d-lysergic acid].
1952